Telephone: 0039 011 633 4371; FAX: 0039 011 633 5194
Original Articles
You have full text access to this OnlineOpen article
Transplantation of hepatitis B surface antigen–positive livers into hepatitis B virus–positive recipients and the role of hepatitis delta coinfection†
Article first published online: 20 JUL 2005
DOI: 10.1002/lt.20471
Copyright © 2005 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Franchello, A., Ghisetti, V., Marzano, A., Romagnoli, R. and Salizzoni, M. (2005), Transplantation of hepatitis B surface antigen–positive livers into hepatitis B virus–positive recipients and the role of hepatitis delta coinfection. Liver Transpl, 11: 922–928. doi: 10.1002/lt.20471
- †
See Editorial on Page 875
- ‡
Telephone: 0039 011 633 4371; FAX: 0039 011 633 5194
Publication History
- Issue published online: 20 JUL 2005
- Article first published online: 20 JUL 2005
- Manuscript Accepted: 1 APR 2005
- Manuscript Received: 2 NOV 2004
References
- 1, , , , , . Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure. Liver Transpl 2003; 9: 1253–1257.
- 2, , , , , , et al.. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation 2002; 27; 73: 1598–1602.
- 3, , , , , , et al. Use of hepatitis B core antibody-positive donors in recipients without evidence of hepatitis B infection: a survey of current practice in the United States. Liver Transpl 2003; 9: 837–842.Direct Link:
- 4, . Use of hepatitis B core antibody-positive donors in recipients without evidence of hepatitis B infection: a survey of current practice in the United States. Liver Transpl 2003; 9: 837–842.Direct Link:
- 5, , , , , , et al. Occult hepatitis B infection in HBsAg negative patients undergoing liver transplantation: clinical significance. Liver Transpl 2004; 10: 356–362.
- 6. Use of hepatitis B core antibody-positive donors for liver transplantation. Liver Transpl 2002; 8(Suppl 1): S82–S87.
- 7, , , , , Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue? J Viral Hepat 2002; 9: 221–228.
- 8, , . Hepatitis B core antibody-positive grafts: recipient's risk. Transplantation 2003; 75(3 Suppl ): S49–S53.
- 9, , , , , , et al. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine. Transplantation 2003; 75: 1179–1186.
- 10, , , , , , et al. Transplantation of a hepatitis B surface antigen-positive donor liver into a hepatitis B virus-negative recipient. Transplantation 1994; 58: 114–116.
- 11
- 12
- 13Gazzetta Ufficiale della Repubblica Italiana. 23 dicembre 2003 (297). Available at: http://www.gazzettaufficiale.it/index/jsp.
- 14, , , , , , et al. Hepatitis B virus (HBV) / hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. J Infect Dis 1996; 174: 920–926.
- 15, , , , , , et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 1991; 101: 1649–1655.
- 16, , , , , , et al. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope. Hepatology 1998; 27: 1723–1729.
- 17. Host and donor risk factors before and after liver transplantation that impact HCV recurrence. Liver Transpl 2003; 9: S44–S47.
- 18, , , , , , et al. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. J Hepatol 1999; 30: 715–721.

1527-6473/asset/LT_left.gif?v=1&s=e1df7d33719b841a3479d2fd0a24baa5df4653e4)
1527-6473/asset/LT_right.gif?v=1&s=5deda9b4c4c603398e58a7274cf47e5b03ffc5fe)
1527-6473/asset/cover.gif?v=1&s=8c6a04b26832399220fbb731e05bd8cc9ff13ae2)